I don't think we need to worry about price manipulation for a low ball takeover. As soon as vivagel for bv starts selling in substantial numbers, it should put a floor under the sp. The next important milestone regarding vivagel is the % we are going to receive for sales. Pretty important to get this right as when these sales figures start improving over the next few years it will make a big difference to our bottom line. Gltah
Viralytics gobbled up.....Why not Starpharma, page-10
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |